What's happening
Writing a plain-English summary… Track this bill to get it by email.
Why it matters
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Headline styles
Sponsors
No co-sponsors yet.
History
- Print number 1197a
- Amend and recommit to health
- Referred to health
- Referred to health
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Provides a program to promote leukemia, lymphoma and myeloma research, education and treatment and establishes the leukemia, lymphoma and myeloma research, education and treatment
Assembly Floor Calendar · Sponsor Michael Cusick
Full text
The text isn't available here yet. Check nysenate.gov.
Sponsor's memo
Title of bill
An act to amend the public health law, the tax law and the state finance law, in relation to providing for taxpayer gifts for leukemia, lymphoma and myeloma research, education and treatment and establishing the leukemia research, education and treatment fund
Purpose or general idea of bill
The purpose of this bill is to provide easy access to help fund and support Leukemia. Lymphoma, and Myeloma research, education and treatment.
Summary of specific provisions
Section 1 - Amends the public health law by adding a new article 27-CCC. The new article provides the Commissioner of Health with the powers to: develop programs concerning Leukemia, Lymphoma. and Myeloma, to accept and expend grants. awards and other funding, and to enter into contracts necessary for program development and granting. Section 2 - Amends the law by adding a new section 209-H. The new section provides for the Commissioner of Taxation and Finance to include a space on the corporate income tax return for contributions to Leukemia, Lymphoma, and Myeloma research, education and treatment. Section 3 - Amends part 2 of article 22 of the tax law by adding new section 630-c. The new section provides for the Commissioner of Taxation and Finance to include a space on the individual income tax return for contributions to Leukemia, Lymphoma, and Myeloma research, education and treatment. Section 4 - Amends the state finance law by adding a new section 97-jjjj. The new section provides for the establishment of a special fund, consisting of revenues received under section 209-H and 630-c of the tax law and any other moneys appropriated, credited or transferred, for Leukemia, Lymphoma and Myeloma research, education and treatment. The custody of this fund will be held jointly by the Commissioner of Taxation and Finance and the Comptroller. Further, the new section provides that all monies in the fund to be used only for Leukemia, Lymphoma and Myeloma research, education and treatment programs approved by the Department of Health. Additionally, the new section provides that the Comptroller must approve releases of money that are certified by the Commissioner of Health and that all money in the fund should be used prior to the end of the fiscal year.
Read the full memo (681 words)
Justification
Research and treatment efforts for many diseases. including Alzheimer's and breast cancer. have benefited from additional funding resulting from having a "check-off box" placed on the individual and corporate income tax returns. Leukemia, Lymphoma and Myeloma are blood cancers originating in the bone marrow and correlate with each other because of the unrestrained growth of the cells and the parallel functions which they possess. Leukemia, although more common in adults over the age of 64, is still the leading cause of disease death of children under 15 yrs old, with Acute Lymphocytic Leukemia (ALL) being the most common form of Leukemia in children. Treatment advances for Leukemia have proven to be prevalent in the survival rate over the years, with the survival rate increasing from 4% in 1960 to 85% in 1999. Lymphoma involves two particular forms including Non-Hodgkin, which is the fifth most common cancer in the U.S. and Hodgkin Lymphoma, which mostly affects adolescents and young adults. Myeloma occurs mostly in people over 60 yrs old with males having a 50% higher chance than females of being diagnosed. Each year an estimated 106.200 people in the United States are diagnosed with Leukemia, Lymphoma, or Myeloma. At the present time, an estimated 670,950 Americans have blood cancers. Approximately 57,500 Americans will die from these hematological malignancies this year. In New York State alone, there
are approximately 6,600 people diagnosed with a blood cancer each year and 3,500 people will succumb to this disease.
Prior legislative history
2009: A.3075 Passed Assembly 2008: A.1558-C Passed Assembly 2007: A.1558-A Passed Assembly 2006: A.3338-A Passed Assembly; S.2871-A Died in Senate Health 2005: A.3338 Passed Assembly 2004: A.9816 Passed Assembly; Died in Senate Health
Fiscal implications
Minimal to the state.
Effective date
This act shall apply to taxable years commencing on or after January 1, 2011.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.